Format
Sort by
Items per page

Send to

Choose Destination

Best matches for López-Mejías R[au]:

IgA Vasculitis: Genetics and Clinical and Therapeutic Management. González-Gay MA et al. Curr Rheumatol Rep. (2018)

Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review. López-Mejías R et al. Autoimmun Rev. (2018)

Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. Fernández-Díaz C et al. Semin Arthritis Rheum. (2018)

Search results

Items: 1 to 50 of 109

1.

Influence of MUC5B gene on antisynthetase syndrome.

López-Mejías R, Remuzgo-Martínez S, Genre F, Pulito-Cueto V, Rozas SMF, Llorca J, Fernández DI, Cuesta VMM, Ortego-Centeno N, Gómez NP, Mera-Varela A, Martínez-Barrio J, López-Longo FJ, Mijares V, Lera-Gómez L, Usetti MP, Laporta R, Pérez V, Gafas AP, González MAA, Calvo-Alén J, Romero-Bueno F, Sanchez-Pernaute O, Nuno L, Bonilla G, Balsa A, Hernández-González F, Grafia I, Prieto-González S, Narvaez J, Trallero-Araguas E, Selva-O'Callaghan A, Gualillo O, Castañeda S, Cavagna L, Cifrian JM, González-Gay MA.

Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0.

2.

Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Quevedo-Abeledo JC, Rúa-Figueroa Í, Sánchez-Pérez H, Naranjo A, de Armas-Rillo L, Tejera-Segura B, Lopez-Mejías R, González-Gay M, Ferraz-Amaro I.

Clin Exp Rheumatol. 2020 Jan 20. [Epub ahead of print]

PMID:
31969232
3.

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.

J Clin Med. 2019 Nov 18;8(11). pii: E2013. doi: 10.3390/jcm8112013.

4.

IL-6: linking chronic inflammation and vascular calcification.

López-Mejías R, González-Gay MA.

Nat Rev Rheumatol. 2019 Aug;15(8):457-459. doi: 10.1038/s41584-019-0259-x. No abstract available.

PMID:
31235835
5.

Genetic Basis of Vasculitides with Neurologic Involvement.

Carmona FD, López-Mejías R, Márquez A, Martín J, González-Gay MA.

Neurol Clin. 2019 May;37(2):219-234. doi: 10.1016/j.ncl.2019.01.006. Epub 2019 Mar 18. Review.

PMID:
30952406
6.

Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.

Martín-Penagos L, Benito A, Oviedo MV, López Del Moral Cuesta C, Martín López J, Gómez Román J, López-Mejías R, Fernandez-Fresnedo G, Ruíz San Millán JC, Rodrigo Calabia E.

Nefrologia. 2019 Sep - Oct;39(5):523-530. doi: 10.1016/j.nefro.2018.10.015. Epub 2019 Mar 20. English, Spanish.

7.

Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.

Castañeda S, Remuzgo-Martínez S, López-Mejías R, Genre F, Calvo-Alén J, Llorente I, Aurrecoechea E, Ortiz AM, Triguero A, Blanco R, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2019 May-Jun;37(3):465-473. Epub 2018 Nov 7.

8.

Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis.

Tejera-Segura B, López-Mejías R, de Vera-González A, Delgado-González A, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2019 May-Jun;37(3):373-379. Epub 2018 Sep 17.

9.

Relationship Between Insulin Sensitivity and β-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis.

Tejera-Segura B, López-Mejías R, de Vera-González AM, Jiménez-Sosa A, Olmos JM, Hernández JL, Llorca J, González-Gay MA, Ferraz-Amaro I.

J Rheumatol. 2019 Mar;46(3):229-236. doi: 10.3899/jrheum.180198. Epub 2018 Oct 1.

PMID:
30275261
10.

Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.

López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, Corrales A, Vicente EF, Pulito-Cueto V, Miranda-Filloy JA, Ramírez Huaranga MA, Blanco R, Robustillo-Villarino M, Rodríguez-Carrio J, Alperi-López M, Alegre-Sancho JJ, Mijares V, Lera-Gómez L, Pérez-Pampín E, González A, Ortega-Castro R, López-Pedrera C, García Vivar ML, Gómez-Arango C, Raya E, Narvaez J, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Gualillo O, Castañeda S, Martín J, Llorca J, González-Gay MA.

Arthritis Rheumatol. 2019 Mar;71(3):351-360. doi: 10.1002/art.40734. Epub 2019 Jan 18.

11.

Association of circulating calprotectin with lipid profile in axial spondyloarthritis.

Genre F, Rueda-Gotor J, Remuzgo-Martínez S, Corrales A, Mijares V, Expósito R, Mata C, Portilla V, Blanco R, Hernández JL, Llorca J, Gualillo O, López-Mejías R, González-Gay MA.

Sci Rep. 2018 Sep 13;8(1):13728. doi: 10.1038/s41598-018-32199-3.

12.

IgA Vasculitis: Genetics and Clinical and Therapeutic Management.

González-Gay MA, López-Mejías R, Pina T, Blanco R, Castañeda S.

Curr Rheumatol Rep. 2018 Apr 2;20(5):24. doi: 10.1007/s11926-018-0735-3. Review.

PMID:
29611051
13.

Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.

Fernández-Díaz C, Loricera J, Castañeda S, López-Mejías R, Ojeda-García C, Olivé A, Rodríguez-Muguruza S, Carreira PE, Pérez-Sandoval T, Retuerto M, Cervantes-Pérez EC, Flores-Robles BJ, Hernández-Cruz B, Urruticoechea A, Maíz-Alonso O, Arboleya L, Bonilla G, Hernández-Rodríguez Í, Palma D, Delgado C, Expósito-Molinero R, Ruibal-Escribano A, Álvarez-Rodríguez B, Blanco-Madrigal J, Bernal JA, Vela-Casasempere P, Rodríguez-Gómez M, Fito C, Ortiz-Sanjuán F, Narváez J, Moreno M, López-Corbeto M, Mena-Vázquez N, Aguilera-Cros C, Romero-Yuste S, Ordóñez S, Villa-Blanco I, Gonzélez-Vela MC, Mora-Cuesta V, Palmou-Fontana N, Hernández JL, González-Gay MA, Blanco R.

Semin Arthritis Rheum. 2018 Aug;48(1):22-27. doi: 10.1016/j.semarthrit.2017.12.012. Epub 2018 Jan 6.

PMID:
29422324
14.

Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.

Ortiz-Fernández L, Carmona FD, López-Mejías R, González-Escribano MF, Lyons PA, Morgan AW, Sawalha AH, Merkel PA, Smith KGC, González-Gay MA, Martín J; Spanish GCA Study Group, UK GCA Consortium, Turkish Takayasu Study Group, Vasculitis Clinical Research Consortium, IgAV Study Group, AAV Study group.

Ann Rheum Dis. 2018 Apr;77(4):589-595. doi: 10.1136/annrheumdis-2017-212372. Epub 2018 Jan 27. Erratum in: Ann Rheum Dis. 2018 Jun;77(6):950.

15.

Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review.

López-Mejías R, Castañeda S, Genre F, Remuzgo-Martínez S, Carmona FD, Llorca J, Blanco R, Martín J, González-Gay MA.

Autoimmun Rev. 2018 Mar;17(3):301-315. doi: 10.1016/j.autrev.2017.11.024. Epub 2018 Jan 17. Review.

16.

Amylin in the insulin resistance of patients with rheumatoid arthritis.

Ferraz-Amaro I, López-Mejias R, Tejera-Segura B, de Vera-González AM, Ubilla B, Olmos JM, Hernández JL, González-Gay MA.

Clin Exp Rheumatol. 2018 May-Jun;36(3):421-427. Epub 2018 Jan 15.

PMID:
29352842
17.

Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients.

Genre F, Rueda-Gotor J, Remuzgo-Martínez S, Corrales A, Ubilla B, Mijares V, Fernández-Díaz C, Portilla V, Blanco R, Hernández JL, Llorca J, López-Mejías R, González-Gay MA.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):302-309. Epub 2017 Dec 15.

18.

Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa.

González-López MA, Lacalle M, Mata C, López-Escobar M, Corrales A, López-Mejías R, Rueda J, González-Vela MC, González-Gay MA, Blanco R, Hernández JL.

PLoS One. 2018 Jan 4;13(1):e0190568. doi: 10.1371/journal.pone.0190568. eCollection 2018.

19.

Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.

López P, Rodríguez-Carrio J, Martínez-Zapico A, Pérez-Álvarez ÁI, López-Mejías R, Benavente L, Mozo L, Caminal-Montero L, González-Gay MA, Suárez A.

Thromb Haemost. 2017 Nov;117(11):2194-2206. doi: 10.1160/TH17-03-0221. Epub 2017 Nov 30.

PMID:
29044294
20.

Incretins in patients with rheumatoid arthritis.

Tejera-Segura B, López-Mejías R, Domínguez-Luis MJ, de Vera-González AM, González-Delgado A, Ubilla B, Olmos JM, Hernández JL, González-Gay MA, Ferraz-Amaro I.

Arthritis Res Ther. 2017 Oct 17;19(1):229. doi: 10.1186/s13075-017-1431-9.

21.

Erratum corrige.

Tejera-Segura B, de Vera-González AM, López-Mejías R, González-Gay MA.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):874. Epub 2017 Sep 15. No abstract available.

22.

Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis.

Remuzgo-Martínez S, Genre F, Castañeda S, Corrales A, Moreno-Fresneda P, Ubilla B, Mijares V, Portilla V, González-Vela J, Pina T, Ocejo-Vinyals G, Irure-Ventura J, Blanco R, Martín J, Llorca J, López-Mejías R, González-Gay MA.

Sci Rep. 2017 Sep 5;7(1):10525. doi: 10.1038/s41598-017-10915-9.

23.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

24.

A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.

López-Mejías R, Carmona FD, Castañeda S, Genre F, Remuzgo-Martínez S, Sevilla-Perez B, Ortego-Centeno N, Llorca J, Ubilla B, Mijares V, Pina T, Miranda-Filloy JA, Navas Parejo A, de Argila D, Aragües M, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, Jayne D, Blanco R, Martín J, González-Gay MA.

Sci Rep. 2017 Jul 11;7(1):5088. doi: 10.1038/s41598-017-03915-2.

25.

High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.

Rodríguez-Carrio J, Alperi-López M, López P, López-Mejías R, Alonso-Castro S, Abal F, Ballina-García FJ, González-Gay MÁ, Suárez A.

J Clin Lipidol. 2017 Jul - Aug;11(4):1043-1054.e2. doi: 10.1016/j.jacl.2017.05.009. Epub 2017 Jun 3.

PMID:
28662934
26.

Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.

Genre F, Armesto S, Corrales A, López-Mejías R, Remuzgo-Martínez S, Pina T, Ubilla B, Mijares V, Martín-Varillas JL, Rueda-Gotor J, Portilla V, Dierssen-Sotos T, González-López MA, González-Vela MDC, Blanco R, Llorca J, Hernández JL, González-Gay MÁ.

J Dermatolog Treat. 2017 Dec;28(8):726-730. doi: 10.1080/09546634.2017.1329498. Epub 2017 May 31.

PMID:
28489469
27.

Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis.

Sánchez-Pérez H, Tejera-Segura B, de Vera-González A, González-Delgado A, Olmos JM, Hernández JL, Corrales A, López-Mejías R, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):885-892. Epub 2017 Mar 8.

PMID:
28281456
28.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

29.

Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study.

Pina T, Corrales A, Lopez-Mejias R, Armesto S, Gonzalez-Lopez MA, Gómez-Acebo I, Ubilla B, Remuzgo-Martínez S, Gonzalez-Vela MC, Blanco R, Hernández JL, Llorca J, Gonzalez-Gay MA.

J Dermatol. 2016 Nov;43(11):1267-1272. doi: 10.1111/1346-8138.13398. Epub 2016 Apr 7.

PMID:
27062420
30.

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.

López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martínez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martín J, González-Gay MA.

Autoimmun Rev. 2016 Nov;15(11):1013-1030. doi: 10.1016/j.autrev.2016.07.026. Epub 2016 Aug 1. Review.

31.

Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.

Ferraz-Amaro I, López-Mejías R, Ubilla B, Genre F, Tejera-Segura B, de Vera-González AM, González-Rivero AF, Olmos JM, Hernández JL, Llorca J, González-Gay MA.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1013-1019. Epub 2016 Aug 31.

PMID:
27606890
32.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

33.

Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis.

Rodríguez-Carrio J, Alperi-López M, López-Mejías R, López P, Ballina-García FJ, Abal F, González-Gay MÁ, Suárez A.

Clin Sci (Lond). 2016 Nov 1;130(21):1889-99. doi: 10.1042/CS20160374. Epub 2016 Aug 12.

PMID:
27520507
34.

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.

Remuzgo-Martínez S, Genre F, López-Mejías R, Ubilla B, Mijares V, Pina T, Corrales A, Blanco R, Martín J, Llorca J, González-Gay MA.

Sci Rep. 2016 Jul 12;6:29713. doi: 10.1038/srep29713.

35.

Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy.

Hernández JL, López-Mejías R, Blanco R, Pina T, Ruiz S, Sierra I, Ubilla B, Mijares V, González-López MA, Armesto S, Corrales A, Pons E, Fuentevilla P, González-Vela C, González-Gay MÁ.

J Osteoporos. 2016;2016:5747852. doi: 10.1155/2016/5747852. Epub 2016 May 12.

36.

Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS).

González-López MA, Hernández JL, Lacalle M, Mata C, López-Escobar M, López-Mejías R, Portilla V, Fuentevilla P, Corrales A, González-Vela MC, González-Gay MA, Blanco R.

J Am Acad Dermatol. 2016 Aug;75(2):329-35. doi: 10.1016/j.jaad.2016.03.025. Epub 2016 Jun 8.

PMID:
27287248
37.

Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis.

Tejera-Segura B, de Vera-González AM, López-Mejías R, González-Gay MA, Ferraz-Amaro I.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):230-5. Epub 2016 Feb 26. Erratum in: Clin Exp Rheumatol. 2017 Sep-Oct;35(5):874.

PMID:
26941186
38.

Sclerostin serum levels in patients with systemic autoimmune diseases.

Fernández-Roldán C, Genre F, López-Mejías R, Ubilla B, Mijares V, Cano DS, Robles CL, Callejas-Rubio JL, Fernández RR, Ruiz ME, González-Gay MÁ, Ortego Centeno N.

Bonekey Rep. 2016 Feb 3;5:775. doi: 10.1038/bonekey.2016.2. eCollection 2016.

39.

Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis.

Remuzgo-Martínez S, Genre F, López-Mejías R, Ubilla B, Mijares V, Pina T, Corrales A, Blanco R, Martín J, Llorca J, González-Gay MÁ.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):106-10. Epub 2016 Feb 2.

PMID:
26843177
40.

Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura.

López-Mejías R, Genre F, Remuzgo-Martínez S, Sevilla Pérez B, Castañeda S, Llorca J, Ortego-Centeno N, Ubilla B, Mijares V, Pina T, Calvo-Río V, Miranda-Filloy JA, Navas Parejo A, Argila D, Sánchez-Pérez J, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, Martín J, Blanco R, González-Gay MA.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S84-8. Epub 2016 Feb 1.

PMID:
26842496
41.

Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease.

Rodríguez-Carrio J, López-Mejías R, Alperi-López M, López P, Ballina-García FJ, González-Gay MÁ, Suárez A.

Arthritis Rheumatol. 2016 Jun;68(6):1367-76. doi: 10.1002/art.39609.

42.

The Framingham Score and the Systematic Coronary Risk Evaluation at Low Cutoff Values Are Useful Surrogate Markers of High-risk Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis.

Dessein PH, Corrales A, Lopez-Mejias R, Solomon A, Woodiwiss AJ, Llorca J, Norton GR, Genre F, Blanco R, Pina T, Gonzalez-Juanatey C, Tsang L, Gonzalez-Gay MA.

J Rheumatol. 2016 Mar;43(3):486-94. doi: 10.3899/jrheum.150510. Epub 2016 Jan 15.

PMID:
26773110
43.

Gene polymorphisms and therapy in rheumatoid arthritis.

Castañeda S, López-Mejías R, González-Gay MA.

Expert Opin Drug Metab Toxicol. 2016;12(3):225-9. doi: 10.1517/17425255.2016.1141405. Epub 2016 Feb 17. No abstract available.

PMID:
26756388
44.

Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, Robledo G, Llorca J, Corrales A, González-Juanatey C, Ubilla B, Mijares V, Pina T, Blanco R, Castañeda S, Martín J, González-Gay MA.

Atherosclerosis. 2016 Feb;245:139-42. doi: 10.1016/j.atherosclerosis.2015.12.011. Epub 2015 Dec 11.

PMID:
26724524
45.

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.

López-Mejías R, Genre F, Remuzgo-Martínez S, Robustillo-Villarino M, García-Bermúdez M, Llorca J, Corrales A, González-Juanatey C, Ubilla B, Miranda-Filloy JA, Mijares V, Pina T, Blanco R, Alegre-Sancho JJ, Ramírez Huaranga MA, Mínguez Sánchez MD, Tejera Segura B, Ferraz-Amaro I, Vicente E, Carmona FD, Castañeda S, Martín J, González-Gay MA.

PLoS One. 2015 Nov 16;10(11):e0143153. doi: 10.1371/journal.pone.0143153. eCollection 2015.

46.

Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis).

López-Mejías R, Genre F, Remuzgo-Martínez S, Pérez BS, Castañeda S, Llorca J, Ortego-Centeno N, Ubilla B, Mijares V, Pina T, Calvo-Río V, Palmou N, Miranda-Filloy JA, Parejo AN, Argila D, Sánchez-Pérez J, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, Ocejo-Vinyals JG, Martín J, Blanco R, González-Gay MA.

Arthritis Res Ther. 2015 Oct 13;17:286. doi: 10.1186/s13075-015-0796-x.

47.

Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy.

Pina T, Genre F, Lopez-Mejias R, Armesto S, Ubilla B, Mijares V, Dierssen-Sotos T, Corrales A, Gonzalez-Lopez MA, Gonzalez-Vela MC, Blanco R, Hernández JL, Llorca J, Gonzalez-Gay MA.

J Dermatol. 2016 Apr;43(4):389-94. doi: 10.1111/1346-8138.13094. Epub 2015 Sep 14.

PMID:
26364678
48.

Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis.

Montes A, Corrales A, Calaza M, Lopez-Mejias R, Parra JA, González-Gay MA, González A.

Arthritis Rheumatol. 2015 Nov;67(11):2861-5. doi: 10.1002/art.39302.

49.

Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.

Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Mijares V, Carnero-López B, Gómez-Acebo I, Dierssen-Sotos T, Remuzgo-Martínez S, Blanco R, Pina T, González-Juanatey C, Llorca J, González-Gay MA.

Rheumatol Int. 2015 Dec;35(12):2069-78. doi: 10.1007/s00296-015-3314-1. Epub 2015 Jul 5.

PMID:
26143161
50.

TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis.

Dessein PH, Lopez-Mejias R, Ubilla B, Genre F, Corrales A, Hernandez JL, Ferraz-Amaro I, Tsang L, Pina T, Llorca J, Blanco R, Gonzalez-Juanatey C, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):491-7. Epub 2015 May 11.

PMID:
25962765

Supplemental Content

Loading ...
Support Center